Liberum Capital reissued their buy rating on shares of Medicx Fund (LON:MXF) in a report published on Friday morning.

Separately, Peel Hunt restated a reduce rating on shares of Medicx Fund in a report on Monday, July 23rd.

Medicx Fund stock opened at GBX 0.78 ($0.01) on Friday. Medicx Fund has a twelve month low of GBX 76.75 ($1.00) and a twelve month high of GBX 92.50 ($1.21).

The firm also recently announced a dividend, which was paid on Friday, September 28th. Investors of record on Thursday, August 16th were issued a dividend of GBX 1.51 ($0.02) per share. This represents a yield of 1.88%. The ex-dividend date of this dividend was Thursday, August 16th.

Medicx Fund Company Profile

MedicX Fund Limited ("MXF", "MedicX Fund", the "Fund" or the "Company", or together with its subsidiaries, the "Group") is the specialist primary care infrastructure investor in modern, purpose-built primary healthcare properties in the United Kingdom and Ireland, listed on the London Stock Exchange, with a portfolio comprising 154 properties.

See Also: What is the Dow Jones Industrial Average (DJIA)?

Receive News & Ratings for Medicx Fund Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medicx Fund and related companies with MarketBeat.com's FREE daily email newsletter.